Data Sheet 1_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.pdf حسب Lijun Wang (176511)

"…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…"

Table 2_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.xlsx حسب Lijun Wang (176511)

"…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…"

Data Sheet 2_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.pdf حسب Lijun Wang (176511)

"…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…"

Table 3_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.xlsx حسب Lijun Wang (176511)

"…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…"

Table 1_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.xlsx حسب Lijun Wang (176511)

"…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…"

Data Sheet 1_Global, regional, and national burden of sudden infant death syndrome, 1990–2021: a comprehensive analysis of GBD 2021 data with insights into the impact during the CO... حسب Yuhan Sun (299077)

"…</p>Conclusions<p>The global SIDS burden has consistently declined since 1990, including during COVID-19, yet significant regional disparities remain. …"

Supplementary Material for: Global, regional, and national burden of brain and central nervous system cancers for males from 1990 to 2021 and its predicted level in the next 25 yea... حسب Maimaiti A. (19938294)

"…Background: A study of the global burden of cerebral and central nervous system (CNS) cancers from the Global Burden of Diseases (GBD) indicates that these cancers significantly contribute to morbidity and mortality internationally. …"

Table 1_Research on the changes in the disease burden of nasopharyngeal carcinoma caused by global occupational formaldehyde exposure from 1990 to 2021 and prediction of future tre... حسب Tingting Duan (5181482)

"…Geographically, there are significant differences in the disease burden among different countries and regions, with South Asia, East Asia, and Africa having the highest disease burden. …"

Supplementary file 1_Comparative analysis of trends in the burden of motor neuron disease in China, the United States, and globally from 1990 to 2021: projections for 2022–2041.doc... حسب Bo Peng (273834)

"…Gender and age analysis revealed that males under 69 bear a higher MND burden. Predictions for 2022–2041 show that in China, male ASIR will decline, while female ASIR will rise, with ASPR, ASMR, and ASDR remaining stable; in the US, male ASIR will rise, ASPR will first increase and then decrease, with ASMR and ASDR remaining stable; globally, ASIR, ASPR, and ASMR will remain stable, while male ASDR will rise and female ASDR will remain stable.…"

Data Sheet 1_Global burden and future trends of gastric cancer in women of reproductive age: estimates from the GBD 2021 Study, 1990–2050.zip حسب Nan Jiang (21252)

"…</p>Results<p>From 1990 to 2021, the GC burden in women aged 15–49 declined globally: ASPR decreased from 10.42 to 5.41 per 100,000 (EAPC −2.11), ASIR from 4.61 to 2.13 (EAPC −2.56), ASMR from 2.02 to 0.89 (EAPC −3.02), and ASDR from 59.6 to 23.8 per 100,000 (EAPC −3.00). …"

Data Sheet 1_Trends in lower extremity peripheral arterial disease incidence since 1990 and forecasting future statistics using Global Burden of Disease 2021: a time-series analysi... حسب Jiacheng Li (826240)

"…Background<p>Lower extremity peripheral arterial disease (LEPAD) significantly affects quality of life and is associated with severe cardiovascular risks. …"

Table 1_A population database analysis to describe the residual burden of varicella in Italy—a high vaccination coverage area—from 2004 to 2022.docx حسب Elisa Barbieri (115023)

"…In the Veneto Region, following the implementation of VV in 2006, the IR significantly decreased by 20.5 annually (95% CI: −23.4, −17.5), ranging from 50.2 per 1,000 person-years in 2006 to 1.2 per 1,000 person-years in 2022.…"

Table 4_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... حسب Wubing Cao (20821589)

"…Background<p>Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, with significant disparities in disease burden across countries and socioeconomic regions. …"

Supplementary file 1_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period... حسب Wubing Cao (20821589)

"…Background<p>Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, with significant disparities in disease burden across countries and socioeconomic regions. …"

Table 2_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... حسب Wubing Cao (20821589)

"…Background<p>Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, with significant disparities in disease burden across countries and socioeconomic regions. …"

Table 1_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... حسب Wubing Cao (20821589)

"…Background<p>Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, with significant disparities in disease burden across countries and socioeconomic regions. …"

Table 3_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... حسب Wubing Cao (20821589)

"…Background<p>Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, with significant disparities in disease burden across countries and socioeconomic regions. …"

Table 7_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... حسب Wubing Cao (20821589)

"…Background<p>Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, with significant disparities in disease burden across countries and socioeconomic regions. …"

Supplementary file 2_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period... حسب Wubing Cao (20821589)

"…Background<p>Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, with significant disparities in disease burden across countries and socioeconomic regions. …"

Table 1_Global burden of pneumoconiosis from 1990 to 2021: a comprehensive analysis of incidence, mortality, and socio-demographic inequalities in 204 countries and territories.doc... حسب Shenyu Zhang (18619540)

"…No correlation was found between the SDI values and the pneumoconiosis burden. Additionally, absolute inequality among SDI countries decreased from 1990 to 2021, whereas relative inequality demonstrated an upward trend during the same period.…"